This inventor holds 1 USPTO granted patent. Top assignee: Conagen Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovative Contributions of Kent S. Boles in Protein Production
Introduction
Kent S. Boles, an accomplished inventor based in La Jolla, California, has made significant strides in the field of biotechnology. With his exceptional expertise and innovative mindset, he has developed groundbreaking methods and systems for producing proteins, particularly therapeutic proteins, through recombinant technology.
Latest Patents
Kent S. Boles holds a patent for the "Production of proteins in labyrinthulomycetes." This invention provides recombinant host cells capable of producing proteins, including therapeutic proteins, and includes nucleic acid constructs designed for the efficient production of these cells. Importantly, the cells developed under this patent encode heterologous proteins, such as antibodies, ensuring that they can effectively secrete these proteins through functional signal sequences detailed within the patent. The methods of producing these proteins represent a significant advancement in biotechnology.
Career Highlights
Kent is currently associated with Conagen Inc., a company renowned for its innovative approach to synthetic biology and advanced biomanufacturing. His role involves leveraging his expertise to enhance the production of proteins through cutting-edge technologies. Over the course of his career, his work has contributed to notable advancements in the field, establishing him as a key figure in protein production innovation.
Collaborations
Kent collaborates with talented professionals like Nicky Caiazza and Jun Urano, both of whom contribute to the dynamic and innovative environment at Conagen Inc. These collaborations foster a rich exchange of ideas, further propelling advancements in the realm of protein production and various biotechnological applications.
Conclusion
Kent S. Boles continues to pave the way in the field of biotechnology through his innovative contributions and collaborations. His patent on protein production is a testament to his dedication to advancing therapeutic solutions. As the industry evolves, the impact of his work will undoubtedly resonate across the sectors that rely on protein-based therapeutics and biotechnologies.